BIBA Publishing message
Click here to view web version
Wednesday, 14 March 2018
Top stories
Durability and sustainability of decompression procedures extended with coflex
The results of a two-year study demonstrate decompression with coflex interlaminar stabilisation extends the durability and sustainability of a decompression procedure. coflex is the first and only motion-preserving, minimally-invasive treatment approved for moderate to severe spinal stenosis post-decompression.
Positive top-line Phase 3 results announced for Taltz in ankylosing spondylitis
Taltz (ixekizumab) met the primary and all key secondary endpoints in COAST-V, a Phase 3 study evaluating the safety and efficacy of Taltz for the treatment of ankylosing spondylitis, also known as radiographic axial spondyloarthritis. The trial included a placebo arm and an active control arm (adalimumab) for comparison with placebo, and studied patients who had never received a biologic disease-modifying anti-rheumatic drug.
Product News
Bioventus to co-develop next generation bone allograft with LifeLink
Bioventus has entered into an agreement with LifeLink Tissue Bank, a division of LifeLink Foundation, to co-develop a next generation bone allograft solution for use in spine and trauma surgery. Terms of the agreement were not disclosed.
Simplify Medical closes additional US$23.25 million in second tranche of series B financing
Simplify Medical has announced a second tranche of its Series B financing of US$23.25 million, completing the oversubscribed round totalling US$44.25 million.
EOS imaging announces new installation in a top-ranking speciality orthopaedic hospital in China
EOS imaging has announced the installation of an EOS system at the Beijing Jishuitan Hospital, a top-ranking speciality orthopaedic hospital in China.
Write to us:
Editor: Suzie Marshall -
suzie@bibamedical.com
Advertise with us:
Elizabeth Sutherst -
elizabeth@bibamedical.com
You are receiving this email because you subscribed/registered on
www.spinalnewsinternational.com
Our mailing address is:
BIBA Medical Ltd,
526 Fulham Road, Fulham, London, SW6 5NR
TEL:
+44 (0)20 7736 8788
FAX:
+44 (0)20 7736 8283
EMAIL:
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number
2944429. VAT registration number
730 6811 50